OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy

Published:2024-07-30 Issue:8 Volume:65 Page:45
ISSN:1552-5783
Container-title:Investigative Ophthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Huang Wei Chieh¹,Ohnsman Christina M.¹,Atiskova Yevgeniya²,Falabella Paulo¹,Spitzer Martin S.²,Schulz Angela³⁴,Dulz Simon²

Affiliation:

1. REGENXBIO Inc., Rockville, Maryland, United States

2. University Medical Center Hamburg-Eppendorf, Hamburg, Germany

3. Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

4. German Center for Child and Adolescent Health (DZKJ), partner site Hamburg, Hamburg, Germany

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Reference32 articles.

1. Current and emerging treatment strategies for neuronal ceroid lipofuscinoses;Kohlschütter;CNS Drugs,2019

2. Visual perception and macular integrity in non-classical CLN2 disease;Atiskova;Graefes Arch Clin Exp Ophthalmol,2022

3. Genetics of the neuronal ceroid lipofuscinoses (Batten disease);Mole;Biochim Biophys Acta,2015

4. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I;Vines;FEBS Lett,1999

5. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses;Kida;Adv Genet,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP